Inventor · disambiguated record
Sanne Lysbet De Haas
Also filed as: DE HAAS SANNE LYSBET
0 granted patents·25 pending applications·0 citations·filing 2010–2016
Top patents by PatentIndex Score
25 records- 0164US2013171135A1Method to identify a patient with an increased likelihood of responding to an anti-cancer therapyHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 0264US2013183300A1Method to identify a patient with an increased likelihood of responding to an anti-cancer therapyHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 0364US2013243758A1Method to identify a patient with an increased likelihood of responding to an anti-cancer therapyHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 0463US2013336960A1Method to identify a patient with an increased likelihood of responding to an anti-cancer therapyHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 0563US2014017231A1Method to identify a patient with an increased likelihood of responding to an anti-cancer therapyHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 0663US2014017232A1Method to identify a patient with an increased likelihood of responding to an anti-cancer therapyHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 0763US2013336959A1Method to identify a patient with an increased likelihood of responding to an anti-cancer therapyHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 0863US2014193397A1Method to identify a patient with an increased likelihood of responding to an anti-cancer therapyHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 0963US2014056874A1Method to identify a pateint with an increased likelihood of responding to an anti-cancer therapyGENENTECH INC·Filed 2013·Application pending·0 cites
- 1063US2014056875A1Method to identify a pateint with an increased likelihood of responding to an anti-cancer therapyGENENTECH INC·Filed 2013·Application pending·0 cites
- 1163US2013344059A1Method to identify a patient with an increased likelihood of responding to an anti-cancer therapyGENENTECH INC·Filed 2013·Application pending·0 cites
- 1263US2014023639A1Method to identify a patient with an increased likelihood of responding to an anti-cancer therapyGENENTECH INC·Filed 2013·Application pending·0 cites
- 1358US2014056876A1Method to identify a pateint with an increased likelihood of responding to an anti-cancer therapyHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 1458US2014023640A1Method to identify a pateint with an increased likelihood of responding to an anti-cancer therapyHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 1557US2013344060A1Method to identify a patient with an increased likelihood of responding to an anti-cancer therapyHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 1652US2014341893A1Blood plasma biomarkers for bevacizumab combination therapies for treatment of breast cancerGENENTECH INC·Filed 2014·Application pending·0 cites
- 1751US2013183303A1Blood plasma biomarkers for bevacizumab combination therapies for treatment of breast cancerHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 1851US2013121999A1Blood plasma biomarkers for bevacizumab combination therapies for treatment of breast cancerHOFFMANN LA ROCHE·Filed 2012·Application pending·0 cites
- 1951US2013183302A1Blood plasma biomarkers for bevacizumab combination therapies for treatment of breast cancerHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 2050US2013315899A1Methods and compositions for diagnostic use in cancer patientsHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 2150US2015004136A1Responsiveness to angiogenesis inhibitorsHOFFMANN LA ROCHE·Filed 2014·Application pending·0 cites
- 2245US2014294768A1Responsiveness to angiogenesis inhibitorsHOFFMANN LA ROCHE·Filed 2014·Application pending·0 cites
- 2344US2017066822A1Responsiveness to angiogenesis inhibitorsHOFFMANN LA ROCHE·Filed 2016·Application pending·0 cites
- 2440US2011064732A1Methods and compositions for diagnostic use in cancer patientsDE HAAS SANNE LYSBET·Filed 2010·Application pending·0 cites
- 2536US2014294811A1Method for predicting risk of hypertension associated with anti-angiogenesis therapyHOFFMANN LA ROCHE·Filed 2014·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Sanne Lysbet De Haas files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →